Paper6131829
Evidence that nalorphine, butorphanol and oxilorphan are partial agonists at a kappa-opioid receptor.
Leander JD. Eur J Pharmacol, 1983. Cited by 84 papers, by iCite.
Cite this record
ConductScience Library. Evidence that nalorphine, butorphanol and oxilorphan are partial agonists at a kappa-opioid receptor. Papers, record 6131829. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6131829
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Evidence that nalorphine, butorphanol and oxilorphan are partial agonists at a kappa-opioid receptor.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Butorphanol | Major topic |
| Morphinans | Major topic |
| Nalorphine | Major topic |
| Narcotic Antagonists | Major topic |
| Receptors, Opioid | Major topic |
| Animals | |
| Male | |
| Rats |
Source PubMed
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 84 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 33608948 | The Oxford Catalogue of Opioids: A systematic synthesis of opioid drug names and their pharmacology. | Br J Clin Pharmacol | 2021 | https://conductscience.org/library/papers/33608948 | PubMed |
| 32913006 | Strategies for Developing κ Opioid Receptor Agonists for the Treatment of Pain with Fewer Side Effects. | J Pharmacol Exp Ther | 2020 | https://conductscience.org/library/papers/32913006 | PubMed |
| 29477761 | Concurrent Assessment of the Antinociceptive and Behaviorally Disruptive Effects of Opioids in Squirrel Monkeys. | J Pain | 2018 | https://conductscience.org/library/papers/29477761 | PubMed |
| 27463799 | Differential Effectiveness of Clinically-Relevant Analgesics in a Rat Model of Chemotherapy-Induced Mucositis. | PLoS One | 2016 | https://conductscience.org/library/papers/27463799 | PubMed |
| 21687823 | Comparison of Antinociceptive Effects Induced by Kappa Opioid Agonists in Male and Female Mice. | Analgesia (Elmsford N Y) | 1999 | https://conductscience.org/library/papers/21687823 | PubMed |
| 17909753 | Evaluation of the mu and kappa opioid actions of butorphanol in humans through differential naltrexone blockade. | Psychopharmacology (Berl) | 2008 | https://conductscience.org/library/papers/17909753 | PubMed |
| 7566372 | Increased locus coeruleus glutamate levels are associated with naloxone-precipitated withdrawal from butorphanol in the rat. | Neurochem Res | 1995 | https://conductscience.org/library/papers/7566372 | PubMed |
| 2852526 | Differential sensitivity of antinociceptive tests to opioid agonists and partial agonists. | Br J Pharmacol | 1988 | https://conductscience.org/library/papers/2852526 | PubMed |
| 2829054 | Secondary reinforcing effects of opiate agonists in mice. | Neurosci Behav Physiol | 1987 | https://conductscience.org/library/papers/2829054 | PubMed |
| 2822190 | Differential sensitivity of models of antinociception in the rat, mouse and guinea-pig to mu- and kappa-opioid receptor agonists. | Br J Pharmacol | 1987 | https://conductscience.org/library/papers/2822190 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6131829
GET https://conductscience.org/api/papers/v1/6131829/authors